Barclays Reiterates “€109.00” Price Target for Hannover Re (FRA:HNR1)

Hannover Re (FRA:HNR1) has been assigned a €109.00 ($126.74) price target by investment analysts at Barclays in a research report issued on Tuesday, February 5th. The firm presently has a “sell” rating on the stock. Barclays‘s target price indicates a potential downside of 15.77% from the company’s previous close.

HNR1 has been the subject of several other research reports. Royal Bank of Canada set a €130.00 ($151.16) price target on shares of Hannover Re and gave the company a “neutral” rating in a research note on Tuesday, December 11th. UBS Group set a €115.00 ($133.72) price target on shares of Hannover Re and gave the company a “neutral” rating in a research note on Thursday, January 3rd. Societe Generale set a €112.00 ($130.23) price target on shares of Hannover Re and gave the company a “neutral” rating in a research note on Thursday, November 8th. Nord/LB set a €118.00 ($137.21) price objective on shares of Hannover Re and gave the stock a “neutral” rating in a research report on Monday, November 19th. Finally, DZ Bank reaffirmed a “neutral” rating on shares of Hannover Re in a research report on Thursday, November 8th. Four analysts have rated the stock with a sell rating and sixteen have issued a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of €114.74 ($133.41).

Shares of FRA HNR1 opened at €129.40 ($150.47) on Tuesday. Hannover Re has a 12-month low of €94.75 ($110.17) and a 12-month high of €116.37 ($135.31).

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Read More: Why is insider trading harmful?

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply